Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€150.94
17.03.22
-
17.03.23
-9.24%
06.03.23

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€138.88
16.10.22
-
16.10.23
-1.35%
06.03.23

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€135.54
28.04.22
-
28.04.23
-4.74%
03.03.23

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.82
13.10.22
-
13.10.23
5.79%
23.02.23

Significant cyclical dependencies
Higher risks for its business
Moderna Inc.

Start price
Target price
Perf. (%)
€126.14
21.02.22
-
21.02.23
19.31%
22.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€158.66
14.02.23
€170.00
14.02.24
-2.31%
18.02.23

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€138.88
16.10.22
-
16.10.23
13.78%
05.02.23

Moderna Inc.

Start price
Target price
Perf. (%)
€144.26
31.01.22
€80.00
31.01.23
10.77%
01.02.23

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€172.00
10.01.23
€180.00
10.01.24
6.47%
18.01.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€233.75
13.12.21
-
13.12.22
-19.03%
14.12.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€180.00
12.12.22
-32.76%
13.12.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€319.25
29.11.21
-
29.11.22
-47.84%
30.11.22

Fair valuation
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Standard Investments for future growth
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€315.00
27.11.21
-
27.11.22
-46.51%
28.11.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€163.88
14.11.22
€180.00
14.11.23
2.82%
26.11.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€164.38
14.11.22
€175.00
14.11.23
9.00%
16.11.22

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€78.55
16.11.20
-
12.11.23
72.12%
18.10.22

Probably not worthwhile Investment
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€272.05
04.12.21
€392.00
04.12.22
-51.71%
21.09.22

Moderna Inc.

Start price
Target price
Perf. (%)
€268.00
19.12.21
€135.00
19.12.22
-48.51%
19.09.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€346.00
07.08.21
-
07.08.22
-46.69%
08.08.22

Moderna Inc.

Start price
Target price
Perf. (%)
€353.00
05.08.21
-
05.08.22
-45.84%
05.08.22

Top 10 in its market
High valuation
Low dividend yield expected
Risky balance sheet
Moderna Inc.

Start price
Target price
Perf. (%)
€299.00
24.07.21
€111.00
24.07.22
-45.65%
25.07.22

Sustainability is little important
Higher risks for its business
Probably not worthwhile Investment
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€301.30
30.11.21
-
30.11.22
-54.65%
30.05.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€158.84
04.04.22
€178.00
04.04.23
-12.49%
19.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€370.95
25.09.21
-
25.09.22
-58.03%
13.04.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€162.42
21.03.22
€180.00
21.03.23
-2.20%
04.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business